Harvard Bioscience (HBIO)
(Delayed Data from NSDQ)
$2.91 USD
-0.21 (-6.73%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $2.94 +0.03 (1.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum B VGM
Brokerage Reports
0 items in cart
Harvard Bioscience, Inc. [HBIO]
Reports for Purchase
Showing records 21 - 40 ( 50 total )
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Moderna, Electroporation and Other "Green Shoots" Increase Growth Visibility
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Clear Turnaround Execution; Raise PT from $9 to $10
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Inaugural Life Sciences & MedTech Conference: Key Takeaways
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Inaugural KBCM Life Sciences & MedTech Forum: Day 2 Takeaways
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Turnaround Accelerating; Raising PT from $6 to $9
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Initiating Coverage on Life Science Technology, Bioproduction, - Diagnostics
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Initiating Coverage with Overweight Rating; Highly Qualified Turnaround CEO
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department